Text OnlyLogin to PAWS Baton Rouge, Louisiana |
Undergraduate graduate faculty alumni
     
Adjunct
Biological
Clinical
Cognitive
Industrial
School
LSU Department of Psychology



Claire D. Advokat

Professor

Biological Area



215, Audubon Hall,
Louisiana State University,
Baton Rouge, LA 70803
Phone:(225)-578-8500
fax:(225)-578-4125

cadvoka@lsu.edu

Click here to view my VITA.

MY RESEARCH INTERESTS:

Psychopharmacology: My primary interest is in understanding the clinical effectiveness and the mechanism of action of drugs used in the treatment of mental illness, such as the antipsychotics, antidepressants, mood stabilizers and anxiolytics. This includes medications used for behavioral disorders as well, such as Attention/Deficit/Hyperactivity Disorder, and dementia.

Two secondary research interests are:

1. The ethics of conducting research investigations.

2. Substance abuse research

TEACHING

I presently teach the following courses:

Drugs and Behavior (4035)

Physiological Psychology (4034)

Biological Basis of Behavior (7034)

Seminar in Psychopharmacology (7039)

MY RECENT PUBLICATIONS:

  • Advokat, C. Amphetamine neurotoxicity and attention-deficit/hyperactivity disorder, Submitted, Journal of Attention Disorders, 2006.

  • Comaty, J. Jr., and C. D. Advokat. 'Real World' study of antipsychotic effectiveness for chronic schizophrenic inpatients in a state psychiatric hospital. In Press, Journal of Mental Health, 2006.

  • Advokat, C., N. Eustis, and J. Pickering. Relationship between diagnosis and disposition of patients admitted to a state psychiatric hospital. Psychiatric Quarterly, 17:97-106, 2005.

  • Advokat, C. Differential effects of clozapine, compared with other antipsychotics, on clinical outcome and dopamine release in the brain. Essential Psychopharmacology, 6:73-90, 2005.

  • Advokat, C.D., and J. E. Comaty. Pharmacoeconomics of the second generation antipsychotics. INVITED PAPER: Contemporary Psychiatry, 3:1-10, 2004.

  • Advokat, C., D. Dixon, J. Schneider, and J. Comaty, Jr. Comparison of risperidone and olanzapine as used under 'Real-World' conditions in a state psychiatric hospital. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 28:487-495, 2004.


    Courses Center

    Document Center